Maxlotec Rises 1.67% Amid COVID-19 (Remdesivir) Theme Uptrend
On the 20th, the COVID-19 (Remdesivir) theme rose by 3.10% compared to the previous day, showing a strong performance, while Maxrotech, a related stock drawing attention, surged by 1.67% compared to the previous day. Maxrotech is known as a manufacturer of wired and wireless gantry robots and engine cylinder blocks for automobiles.
[Graph] Major stock price changes in the COVID-19 (Remdesivir) theme

According to the analysis by Thinkpool Robo Algorithm RASSI, Maxrotech's quant financial score is 1.07, which is lower in stability, profitability, and growth compared to the average of other stocks related to COVID-19 (Remdesivir). This can be interpreted as Maxrotech having relatively low investment attractiveness compared to other stocks from a financial perspective. On the other hand, BC World Pharm ranked first in quant financial ranking with higher growth, stability, and profitability scores compared to the average of other stocks.
[Table] Top stocks by financial score within the theme

※ The quant financial score is the result of the Robo Algorithm analyzing each company's sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.
※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
Hot Picks Today
"Heading for 2 Million Won": The Company the Securities Industry Says Not to Doubt [Weekend Money]
- School Sports Days Shrinking Due to Noise Complaints: National Police Agency Directs Officers to Refrain from Dispatch
- "Drink Three Cups of Coffee and Stay Up All Night Before the Test"... Manual of Insurance Planner Who Collected 1 Billion Won in Payouts
- "Anyone Who Visited the Room Salon, Come Forward"… Gangnam Police Station Launches Full Staff Investigation After New Scandal
- "Envious of Korean Daily Life"...Foreign Tourists Line Up in Central Myeongdong from Early Morning [Reportage]
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.